Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03157700 · ClinicalTrials.gov registry record · NA

Interactive Technology for Media Literacy Drug Prevention in Community Groups

A NA study of Substance Use, sponsored by Real Prevention.

Completed
Registry status
NA
Development phase
642
Enrollment target
1
Study location

NCT03157700 is a NA study of Substance Use that has completed, run by Real Prevention. The registered enrollment target is 642 participants, below the 1,253-participant average among 88 other Substance Use trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03157700, a NA study of Substance Use, has completed, sponsored by Real Prevention.

COMPLETED
Registry status
NA
Development phase
642 participants
Enrollment target
1
Study location

Study Summary

This Phase II STTR will evaluate an interactive, self-paced, e-learning media literacy intervention, REAL media, to prevent youth substance use among youth in the 4-H organization. Participating 4-H clubs will be randomly assigned to use the curriculum or continue current practices with the option for delivery at the end of the study. 4-H members (ages 13-15) will complete a pretest, immediate posttest and follow-up posttests at 3 and 9 months to assess effects.

Conditions Studied

Interventions

  • BEHAVIORAL REAL media curriculum

Study Locations (1)

New Jersey

  • Rutgers, The State University of New Jersey - New Brunswick

Trial Details

FieldValue
Enrollment Target 642 participants
Start Date 2018-08-08
Est. Completion 2019-08-22
Phase NA

Sponsor

Real Prevention

5 total trials

What the Registry Record Tells You About NCT03157700

The ClinicalTrials.gov registry entry for NCT03157700 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 642 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,253-participant average among 88 other Substance Use trials with a reported enrollment target (49% lower). The listed sponsor is Real Prevention, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which REAL media curriculum is the first listed.

NCT03157700 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT03157700 about?

NCT03157700 is a clinical study titled "Interactive Technology for Media Literacy Drug Prevention in Community Groups". This Phase II STTR will evaluate an interactive, self-paced, e-learning media literacy intervention, REAL media, to prevent youth substance use among youth in the 4-H organization. Participating 4-H clubs will be randomly assigned to use the curriculum or continue current practices with the option f...

What is the current status of trial NCT03157700?

This trial is currently completed. It is a NA study. The enrollment target is 642 participants. The study started on 2018-08-08. Estimated completion is 2019-08-22.

What conditions does trial NCT03157700 study?

This clinical trial studies the following conditions: Substance Use.

What interventions are being tested in trial NCT03157700?

The interventions under investigation include: REAL media curriculum (BEHAVIORAL).

Who is sponsoring clinical trial NCT03157700?

This trial is sponsored by Real Prevention, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03157700 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.